Welcome

Drug-Price Transparency Pushed as Seniors Confront Rising Bills

March 7, 2019, 6:28 PM

Rising prescription drug prices are driving a Senate committee to scrutinize how Americans can learn what medicines cost at the pharmacy.

Aging Committee members are exploring ways to require drugmakers and pharmaceutical middlemen to pass discounts on to consumers, rather than pocket them, and to address patent abuses, Chairwoman Susan Collins (R-Maine) said.

“We must do more to ensure these medicines are more affordable and their prices more transparent,” Collins said. “Addressing the rising cost of prescription drugs is the top priority for this committee.”

Sen. Susan Collins
Al Drago-Pool/Getty Images

The panel, which held two of three planned hearings on drug prices this week, ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.